What is it about?

This work characterizes the toxicokinetics and toxicity of oxiracetam and (S)-oxiracetam in an acute study and a 13-week repeated oral dose study in beagle dogs. The results suggest that (S)-oxiracetam could be a superior medication compared to racemic oxiracetam.

Featured Image

Why is it important?

Observations on the dose-exposure relationship in dogs are also provided. These findings may provide further insight into the toxicological evaluation of chiral drugs.

Read the Original

This page is a summary of: Comparative toxicity and toxicokinetic studies of oxiracetam and (S)-oxiracetam in dogs, Xenobiotica, October 2018, Taylor & Francis,
DOI: 10.1080/00498254.2018.1528027.
You can read the full text:

Read

Contributors

The following have contributed to this page